Forever Labs Backs FDA Citizen Petition to Ease Stem Cell Rules, Boost Patient Access and U.S. Manufacturing
2026-01-28
PubComNonGov2026-01-28
Carter Struck
WASHINGTON, Jan. 28 -- Forever Labs Inc., a U.S.-based bio-repository focused on banking autologous mesenchymal stem cells, has submitted a public comment letter to the Food and Drug Administration (F . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, Jan. 28 -- Forever Labs Inc., a U.S.-based bio-repository focused on banking autologous mesenchymal stem cells, has submitted a public comment letter to the Food and Drug Administration (F . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2026